{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:41:11Z","timestamp":1792543271236,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.2215\/cjn.00210110","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T22:13:26Z","timestamp":1276208006000},"page":"1588-1594","source":"Crossref","is-referenced-by-count":31,"title":["Multiple-Dose Pharmacokinetics and Pharmacodynamics of N-Acetylcysteine in Patients with End-Stage Renal Disease"],"prefix":"10.2215","volume":"5","author":[{"given":"Thomas D.","family":"Nolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Ouseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"McMenamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230601","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-9-20230601","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"R3-9-20230601","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1054-3589(08)60985-0","article-title":"N-acetylcysteine: Pharmacological considerations and experimental and clinical applications","volume":"38","author":"Cotgreave","year":"1997","journal-title":"Adv Pharmacol"},{"key":"R4-9-20230601","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"R5-9-20230601","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2014a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"R6-9-20230601","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstrom","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R7-9-20230601","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine","volume":"34","author":"Olsson","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"R8-9-20230601","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/bdd.2510110205","article-title":"Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man","volume":"11","author":"Borgstrom","year":"1990","journal-title":"Biopharm Drug Dispos"},{"key":"R9-9-20230601","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00228-004-0862-9","article-title":"Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise","volume":"60","author":"Brown","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"R10-9-20230601","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00228-004-0850-0","article-title":"Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients","volume":"60","author":"Soldini","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"R11-9-20230601","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00044011-200626040-00003","article-title":"Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease","volume":"26","author":"Thaha","year":"2006","journal-title":"Clin Drug Investig"},{"key":"R12-9-20230601","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000106103","article-title":"Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients","volume":"25","author":"Sahin","year":"2007","journal-title":"Blood Purif"},{"key":"R13-9-20230601","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CNP69024","article-title":"Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients","volume":"69","author":"Thaha","year":"2008","journal-title":"Clin Nephrol"},{"key":"R14-9-20230601","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/ajkd.2003.50054","article-title":"The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: A randomized, controlled study","volume":"41","author":"Friedman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R15-9-20230601","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000109492.65802.AD","article-title":"Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure","volume":"109","author":"Scholze","year":"2004","journal-title":"Circulation"},{"key":"R16-9-20230601","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5414\/CNP59441","article-title":"N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients\u2014a pilot study","volume":"59","author":"Trimarchi","year":"2003","journal-title":"Clin Nephrol"},{"key":"R17-9-20230601","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"R18-9-20230601","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jchromb.2007.02.024","article-title":"Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: Application to studies of oxidative stress","volume":"852","author":"Nolin","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R19-9-20230601","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.jchromb.2009.05.046","article-title":"Simultaneous analysis of multiple aminothiols in human plasma by high performance liquid chromatography with fluorescence detection","volume":"877","author":"McMenamin","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R20-9-20230601","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ab.2006.03.010","article-title":"Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column","volume":"353","author":"de Jong","year":"2006","journal-title":"Anal Biochem"},{"key":"R22-9-20230601","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"R23-9-20230601","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"R24-9-20230601","first-page":"245","article-title":"Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial","volume":"4","author":"Pendyala","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R25-9-20230601","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"R26-9-20230601","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/clpt.2008.59","article-title":"Emerging evidence of the impact of kidney disease on drug metabolism and transport","volume":"83","author":"Nolin","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R27-9-20230601","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1681\/ASN.2009010082","article-title":"ESRD impairs nonrenal clearance of fexofenadine but not midazolam","volume":"20","author":"Nolin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R28-9-20230601","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/tx980018b","article-title":"Acylase I-catalyzed deacetylation of N-acetyl-L-cysteine and S-alkyl-N-acetyl-L-cysteines","volume":"11","author":"Uttamsingh","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"R29-9-20230601","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.biocel.2007.04.014","article-title":"Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes","volume":"39","author":"Raftos","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"R30-9-20230601","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/ndt\/5.12.1018","article-title":"Alterations of the Cl\u2212\/NaCO3 \u2212 anion exchanger in erythrocytes of uraemic patients","volume":"5","author":"Maduell","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"R31-9-20230601","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00365519409085464","article-title":"Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine","volume":"54","author":"Hultberg","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"key":"R32-9-20230601","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0021-9150(95)05635-1","article-title":"N-Acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels","volume":"119","author":"Wiklund","year":"1996","journal-title":"Atherosclerosis"},{"key":"R33-9-20230601","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/CCLM.2002.086","article-title":"Effects of oral N-acetylcysteine on plasma homocysteine and whole blood glutathione levels in healthy, non-pregnant women","volume":"40","author":"Roes","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"R34-9-20230601","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/phrs.1999.0519","article-title":"N-Acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion","volume":"40","author":"Ventura","year":"1999","journal-title":"Pharmacol Res"},{"key":"R35-9-20230601","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.freeradbiomed.2007.06.019","article-title":"The relationship between dose of vitamin E and suppression of oxidative stress in humans","volume":"43","author":"Roberts","year":"2007","journal-title":"Free Radic Biol Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201009000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:42Z","timestamp":1786369242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201009000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00210110","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}